Answers are grounded in this paper and cite their sources.
Circulating A-FABP levels are associated with long-term prognosis in patients with coronary heart disease and may represent an important pathophysiological mediator of atherosclerosis, which may point to a new target of treatment options.
No takes yet. Share an insight, caveat, or question.
Eynatten et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: